This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Endoscopic submucosal dissection (ESD) is a minimally invasive procedure used to remove large or deeply embedded gastrointestinal tumors. It is a type of endoscopy where a thin, flexible tube is inserted into the gastrointestinal tract and the tumor is excised using a high-frequency electric current. The procedure is usually done under general anesthesia. In ESD, the endoscope is inserted through the mouth into the stomach and duodenum. Once the tumor is located, a thin knife is used to dissect the tumor from the underlying tissue. The knife is then used to cut a narrow channel around the tumor, and the tumor is then removed by cutting it away from the surrounding tissue. The cut is sealed with an endoscopic clip or suture. The advantages of ESD include less pain, fewer complications, and a shorter recovery time compared to traditional surgery. It is also less costly due to less time spent in the operating room and fewer complications. The risks associated with ESD include bleeding, infection, and perforation of the gastrointestinal tract. In addition, some tumors may not be completely removed, and there is a risk of recurrence. ESD is a safe and effective procedure for the removal of large or deeply embedded tumors in the gastrointestinal tract. It is less invasive than traditional surgery and has a shorter recovery time. However, it is important to discuss the risks with your doctor before undergoing the procedure.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States